Pharmafile Logo
Pharmafocus logo
Advanced Search

donidalorsen

Showing 1 posts of 1 posts found.

MHRA authorises donidalorsen for hereditary angioedema prevention

May 27, 2026
Research and Development donidalorsen

Otsuka Pharmaceuticals UK announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has authorised Dawnzera (donidalorsen) for routine prevention …

News
The Gateway to Local Adoption Series

Latest content

Santen joins inaugural Global Summit for Eye Health as partner

August 14, 2026

EHP Awards 2027 open for entries following outstanding inaugural year

August 13, 2026

NHS spends £240m storing patient records as digital reforms gather pace

August 13, 2026

NHS awards national diabetes education contract to Leicester programme

August 12, 2026

InnoScot highlights NHS Scotland’s progress towards net zero healthcare

August 11, 2026